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Rhomboids are evolutionarily conserved serine pro-
teases that cleave transmembrane proteins within
the membrane. The increasing number of known
rhomboid functions in prokaryotes and eukaryotes
makes them attractive drug targets. Here, we
describe structures of the Escherichia coli rhomboid
GlpG in complex with b-lactam inhibitors. The inhib-
itors form a single bond to the catalytic serine and
the carbonyl oxygen of the inhibitor faces away
from the oxyanion hole. The hydrophobic N-substitu-
ent of b-lactam inhibitors points into a cavity within
the enzyme, providing a structural explanation for
the specificity of b-lactams on rhomboid proteases.
This same cavity probably represents the S20 sub-
strate binding site of GlpG. We suggest that the
structural changes in b-lactam inhibitor binding
reflect the state of the enzyme at an initial stage of
substrate binding to the active site. The structural
insights from these enzyme-inhibitor complexes
provide a starting point for structure-based design
for rhomboid inhibitors.
INTRODUCTION
Recent identification of intramembrane proteases has revealed a
new strategy for cellular regulation, whereby membrane proteins
inactive in their membrane-bound form are activated by site-
specific intramembrane proteolytic cleavage within the trans-
membrane (TM) helix. The domains that are released upon
proteolysis move to new locations to carry out specific biologic
functions (Brown et al., 2000). Rhomboids are a family of intra-
membrane proteases that use a catalytic dyad of serine and
histidine for proteolysis of TM substrates (Freeman, 2008).
Beyond their initial identification in Drosophila as primary regula-
tors of the EGF receptor signaling pathway (Wasserman et al.,
2000), the expanding biologic roles of rhomboids include protein
translocation, parasite invasion, and mitochondrial remodeling
(Freeman, 2008; Urban and Dickey, 2011). Understanding how
rhomboids cleave their substrate TM domains is an active area
of research, and the importance of rhomboids in variousStructure 21, 10signaling pathways has highlighted them as attractive drug
targets.
The structures of prokaryotic homologs of rhomboid prote-
ases provided the first views of the architecture of an intramem-
brane protease family, revealing the active site in a water-filled
environment surrounded by TM helices (Ben-Shem et al.,
2007; Lemieux et al., 2007; Wang et al., 2006; Wu et al., 2006).
Substrates are thought to interact with the enzyme through a
gap between TM helices. Although rhomboids do not recognize
a simple primary sequence in their substrate, a widespread
substrate motif has been identified. This motif reveals that for
many rhomboids, there is a preference for amino acids with small
side chains at the P1 position, where the peptide bond cleavage
occurs. On either side of this scissile bond, hydrophobic resi-
dues might play a role in increasing the specificity of the sub-
strate (Moin and Urban, 2012; Strisovsky et al., 2009). It was
noted very early that, besides isocoumarins, many of the clas-
sical serine protease inhibitors were ineffective against rhom-
boids, thus raising the question of whether rhomboids use a
distinct mechanism for catalysis (Urban et al., 2001; Urban and
Wolfe, 2005). However, fluorophosphonates have recently also
been shown to inhibit rhomboids (Sherratt et al., 2012; Xue and
Ha, 2012). The structures of rhomboid proteases in complex
with isocoumarins and fluorophosphonates have extended our
understanding of how a substrate might bind at the active
site, what associated structural changes in the enzyme might
occur, and a plausible mechanism for intramembrane proteoly-
sis (Vinothkumar et al., 2010; Xue et al., 2012; Xue and Ha, 2012).
Recently, monocyclic b-lactams (also called monobactams)
were identified as inhibitors of rhomboid proteases (Pierrat
et al., 2011). Using chymotrypsin as a control serine protease,
the parent b-lactam was used to design inhibitors with improved
selectivity and potency for rhomboid proteases. These inhibitors
were also shown to have some activity in vivo, both in
Escherichia coli and in mammalian cells. The structure-activity
relationship (SAR) of the inhibitors highlighted key chemical
groups that were essential for activity and potency against
rhomboid proteases (Pierrat et al., 2011).
To address themechanism of b-lactam inhibition and its mode
of binding to rhomboids, we determined structures of E. coli
GlpG in complex with three different b-lactam inhibitors. The
acyl enzyme structures define the S20 substrate binding site in
GlpG and reveal a preference for large hydrophobic groups in
this position. Comparisons with previously published rhomboid
structures highlight the changes essential for initial binding of51–1058, June 4, 2013 ª2013 Elsevier Ltd All rights reserved 1051
Figure 1. Structures of GlpG in Complex
with b-Lactam Inhibitors
(A) Mechanism of b-lactam inhibition of serine
proteases. The nucleophilic attack of the carbonyl
group at position 2 of the b-lactam ring by catalytic
serine results in ring opening to form an acyl
enzyme (Powers et al., 2002).
(B) The different N-substituent in each of the
structures is described here. A 2Fo-Fc map (blue
mesh) contoured at 1.0 s around the catalytic
serine, and the inhibitors are shown in stick rep-
resentation.
(C) An overview of the GlpG in complex with L62.
The phenyl group at position 4 points toward the
gap between TM2 and TM5 (yellow). The sub-
stituent at the carbamate points into the enzyme.
The active site residues, S201 and H254 and the
inhibitor, are shown in stick representation.
(D) Interactions of L62 with GlpG. Most
interactions between the inhibitors and the
enzyme are common in all three structures; the
interaction of L62 is shown here. Water molecules
are shown as red spheres and the hydrogen bonds
are shown as red lines. The carbonyl oxygen
points away from the oxyanion hole and is close to
the side chain of H254. A water molecule forms
hydrogen bonds with the carbamate oxygen of
L62, the hydroxyl of Y205, and the backbone
carbonyl of W236. Residues H150, G198, and
S201 hydrogen-bond with another water mole-
cule, which in other inhibitor structures of GlpG is
displaced. The hydrogen bond between the
nitrogen atom of the inhibitor and the side chain of
N154 further strengthens the interaction between
the enzyme and inhibitor.
(E) A 2fo-fc map at 1s (blue mesh) drawn around
the uncleaved b-lactam inhibitor (magenta) at the
TM2/TM5 interface. The side chains of amino
acids (carbon atoms shown in gray) that
hydrogen-bond (red lines) with the oxygen atoms
of this external inhibitor include W236 and W157.
Note that the C4 carbon of the uncleaved L62 has
the opposite chirality of the L62 covalently bound
to S201 (shown in green stick representation).
See also Figures S1 and S2.
Structure
Rhomboid Protease Inhibition by b-lactamsthe substrates and formation of the S20 cavity. The differences in
the nature of residues lining the S20 cavity in rhomboids could
form the basis for observed selectivity and specificity of
b-lactams and substrates.
RESULTS
Structures of GlpG in Complex with b-Lactams
The inhibition of serine proteases by b-lactams involves the
nucleophilic attack by the serine hydroxyl group on the carbonyl
group of the inhibitor, resulting in opening of the b-lactam ring
(Powers et al., 2002) (Figure 1A). Initial maps after molecular
replacement in many data sets of GlpG crystals soaked with
the inhibitors show the presence of continuous density at the
active serine, indicating the formation of an ester bond between
the enzyme and inhibitors (Figure 1B). All the structures
described here derive from the same parent compound with a
carbamate attached to the nitrogen atom (Pierrat et al., 2011).
The carbamate substituent is a phenyl (inhibitor L29), isobutyl1052 Structure 21, 1051–1058, June 4, 2013 ª2013 Elsevier Ltd All ri(inhibitor L61), or a cyclopentyl (inhibitor L62). The crystals of
GlpG soaked with all b-lactams described here diffracted to
2.2–2.4 A˚ resolutions (Table 1) and are very similar, withminor dif-
ferences in the loop regions (Figure 1C; Figure S1 and Table S1
available online). A complete loop5 (residues 245–249), with the
exception of F245 side chain, could be modeled into the L62
structure. While in the L61 structure, all residues of loop5 except
for F245 could be modeled. We have included two data sets of
GlpG soaked with L29, which are similar but differ in map quality
in certain regions of protein and water molecules (Figure S1;
Table S1). In the first data set, which diffracts to 2.2 A˚, loop5 is
disordered, while in the second data set, which diffracts to
2.4 A˚, the main chain atoms for residues 245–247 of loop5 could
be modeled. Although a racemic mixture was used for soaking,
the best fit to the density was observed for the R-enantiomer.
The phenyl ring at position 4 of the b-lactams (Figure 1A), which
is common to all three inhibitors, points into the gap between
TM2andTM5 toward theputative bilayer. Thecarbamate substit-
uents point into the interior of the enzyme (Figures 1C and 1D).ghts reserved
Table 1. Data Collection and Refinement Statistics
Parameter L29 Data Set 1 (3ZMI) L29 Data Set 2 (3ZOT) L61 (3ZMJ) L62 (3ZMH)
Cell Dimensions
a, b, c (A˚) 110.5, 110.5, 128.5 110.2, 110.2, 128.9 110.2, 110.2, 128.2 110.1, 110.1, 128.5
g () 120 120 120 120
Resolution (A˚)a 55.2–2.2 (2.3–2.2) 53.4–2.4 (2.49–2.4) 53.2–2.3 (2.4–2.3) 76.6–2.30 (2.4-2.3)
Rmerge 0.062 (0.451) 0.072 (0.457) 0.068 (0.589) 0.113 (0.678)
I/sI 16.2 (3.8) 12.6 (3.1) 14.4 (3.0) 10.9 (2.6)
Completeness (%) 99.3 (100) 99.5 (99.8) 99.2 (99.9) 100 (99.9)
Redundancy 5.2 (5.3) 4.8 (5.0) 5.2 (5.2) 5.9 (6.1)
Wilson B factor (A˚2) 43.2 37.2 40.9 34.2
Refinement
Resolution (A˚) 44.8–2.2 53.4–2.4 53.2–2.3 76.6–2.3
No. of reflections 15,423 11,900 13,416 13,542
Rwork / Rfree
b 0.217/0.261 0.198/0.252 0.197/0.231 0.188/0.23
No. of Atoms
Total 1,482 1,540 1,513 1,564
Protein 1,393 1,421 1,431 1,445
Ligandc 20 20 18 19
Heteroatomsc 39 70 37 62
Water 30 29 27 38
B-Factors (A˚2)
Total 46.6 38.9 42.0 34.7
Protein 46.1 38.2 41.6 34.2
Ligand 56.2 46.6 53.7 36.3
Heteroatoms 58.0 51.0 50.6 44.9
Water 47.5 37.6 42.1 37.1
Rmsd
Bond lengths (A˚) 0.008 0.008 0.007 0.007
Bond angles () 1.05 1.1 1.01 1.02
Rmsd, root-mean-square deviation.
aValues in parentheses are for the highest-resolution shell.
bA subset of reflections (5%) imported from apoenzyme (2XOV) was used for calculation of Rfree and remaining (95%) reflections was used for
calculation of Rwork.
cHeteroatoms denote detergent, ions, and exogenous b-lactam. Ligand denotes the b-lactam covalently bonded to S201.
Structure
Rhomboid Protease Inhibition by b-lactamsA number of polar and hydrophobic interactions between the
inhibitor and amino acid residues in the enzyme are observed.
The carbonyl oxygen of the inhibitors points away from the
oxyanion hole but is close to the Nε of H254 and the observed
distance varies between 3.15 and 3.5 A˚ (Figure 1D; Figure S1).
Because the carbonyl oxygen points away from the oxyanion
hole, this space is occupied by awater molecule as in the apoen-
zyme and hydrogen-bonds to the side chains of H150, S201, and
the backbone of G198. The interaction of inhibitor with the
enzyme is further stabilized by a hydrogen bond between the
nitrogen atom of the inhibitor and the side chain of N154. In
the L29 and L62 structures, the carbamate oxygen of the
inhibitor hydrogen-bonds to a water molecule, which in turn
hydrogen-bonds to the side chain hydroxyl of Y205 and back-
bone carbonyl of W236. This interaction is absent in the L61
structure because the carbamate oxygen points toward TM5
(Figure S1F). The phenyl group at position 4 interacts with hydro-
phobic residues including M149, F153, W157 from TM2, W236
from TM5, and M247 from loop5 and has rotational freedom. InStructure 21, 10the L29 structure, the aromatic ring is rotated 90 when
compared to the L61 and L62 structures (Figure 1B; Figure S1).
In the structure of GlpG in complex with L62, an additional
density was observed at the interface between TM2 and TM5.
The shape of the density suggested that it might represent a
second inhibitor molecule, which is consistent with the high
concentrations of inhibitor used in the soak. The best fit was
observed for an uncleaved L62 molecule with an intact b-lactam
ring (Figure 1E). The modeled inhibitor fits nicely into a groove
formed between TM2 and TM5 (Figure S2). The side chains of
W157 and W236 form a hydrogen bond with the oxygen atoms
of the inhibitor and hydrophobic interactions between the
b-lactam and residues of TM2 and TM5, in particular F153,
W157, F232 and W236, are observed.
S20 Cavity
Based on the previously published isocoumarin structure, we
predicted that upon inhibitor binding, a hydrophobic cavity is
formed downstream of the active site, which could represent51–1058, June 4, 2013 ª2013 Elsevier Ltd All rights reserved 1053
Figure 2. S20 Cavity of GlpG
(A) In all the structures described here, the sub-
stituent at the carbamate position points into a
cavity in GlpG, formed only upon inhibitor binding
in this crystal form. In this example, inhibitor L61 is
shown pointing into the cavity.
(B) This cavity, hypothesized as the S20 substrate
binding site, is largely hydrophobic formed by
residues from TM2, TM4, and TM5. The side chain
of M208 forms the base of the cavity. The aromatic
rings of W157, Y205, and W236 form the walls of
the cavity. The side chains of V204, A233, and I237
point into the cavity.
(C) A typical plot used to estimate the IC50 values
of inhibitors. After inhibition of GlpG (350 nM) with
different concentrations of inhibitors, substrate
(3.5 mM) was added and incubated for 45 min at
37C. The cleaved products were separated by
SDS gels. The intensity of the bands were quan-
tified with ImageJ and the activity (as a percentage
of control) was plotted against the inhibitor con-
centration. The data were fit to a four-parameter
dose-response curve for determination of the IC50
values.
(D) A table showing the average IC50 values (± SE)
of different substituents of the inhibitor from three
independent experiments. Compounds bearing
larger hydrophobic groups are more potent in-
hibitors of GlpG.
See also Figure S3.
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Rhomboid Protease Inhibition by b-lactamsthe S20 substrate binding site of GlpG (where the P20 residue of
substrate interacts) (Vinothkumar et al., 2010). In all the struc-
tures described here, this cavity is filled with hydrophobic carba-
mate substituents (Figure 2A). Residues from TM 2, TM 4, and
TM 5 form the cavity. The side chain of M208 forms the base
of the cavity, while the aromatic rings of W157, Y205, and
W236 form the sides of the wall. Residues V204 in TM4, and
A233 and I237 in TM5 also form part of the cavity (Figure 2B).
To address a possible preference for certain chemical motifs
binding in the S20 cavity, we analyzed the influence of different
hydrophobic carbamate groups on GlpG inhibition, which
revealed an interesting correlation between size and potency
(Figures 2C and 2D; Figure S3). The larger hydrophobic groups
such as phenyl (L29), benzyl (L59), or 4-chlorophenyl (L60)
inhibited GlpGmore potently. In contrast, introduction of smaller
and less hydrophobic groups such as a cyclopentane ring or
isobutyl group showed a higher half maximal inhibitory concen-
tration (IC50) value (Figure 2D). It is evident that the best fit for the1054 Structure 21, 1051–1058, June 4, 2013 ª2013 Elsevier Ltd All rights reservedS20 cavity is achieved by larger hydro-
phobic groups such as an aryl ring
(L29), explaining why the smaller isobutyl
group is less active.
The formation of a single covalent
bond between b-lactam inhibitors and
the enzyme indicates that it should
be possible to regenerate the enzyme
activity by hydrolysis of the ester bond.
Indeed, upon rapid dilution of inhibitor-
bound rhomboid protease, a modest
recovery of the activity was observed(Pierrat et al., 2011). To ascertain whether different hydrophobic
groups affect the rate of reactivation of GlpG, the spontaneous
recovery of activity of the b-lactam-inhibited enzyme over time
was monitored (Figure S4A). Slow recovery of activity was
observed for all inhibitors. GlpG inhibited with b-lactams L29 or
L60 showed 50% recovery of wild-type (WT) activity within 6
and 3.5 hr, respectively. b-lactams with smaller hydrophobic
groups, L61 and L62, required >24 hr to attain 50% WT activity
(Figures S4A and S4B). The benzyl carbamate (L59) showed an
intermediate behavior with 50% activity regained after 17 hr.
This process of reactivation could be accelerated by the addition
of hydroxylamine, a nucleophile more powerful than water.
Incubation of enzyme-inhibitor complex with hydroxylamine
restored 70%–80% activity of GlpG within 30 min (Figure S4C).
Analogous to chymotrypsin, where the rate of deacylation was
observed to be dependent on the chemical groups (Ingles
et al., 1966), the difference in the rate of deacylation of b-lactams
in GlpG may reflect the nature of each hydrophobic group’s
Figure 3. Comparison of GlpG Structures
(A) An overlay of GlpG apoenzyme (2XOV) and the
b-lactam-bound structure (L62). The overall
structural change in the enzyme upon inhibitor
binding is minor, with modest changes in TM5 and
loop5. The carbon atoms of inhibitor molecule
(yellow), the side chains of active site residues
(S201 and H254), and M249 from loop5 are shown
in stick representation. In both structures, the side
chain of M249 points into the active site.
(B) A close-up view of the active sites of the
apoenzyme and GlpG in complex with b-lactam
(L62). Key residues in the active site are repre-
sented as sticks, and the carbon atoms are either
green (apoenzyme) or magenta (L62). The change
in the side chain of W236 upon inhibitor binding is
clearly evident.
(C) An overlay of the GlpG L62 structure and GlpG
S201T (2XTU). The inhibitors, detergentmolecules,
catalytic serine, and side chains of loop5 are
shown in stick representation. The carbon atoms
of inhibitor molecules in the L62 structure are
white, and detergent molecules in the GlpG S201T
structure are yellow. The structural change in TM5
is marked with an arrow.
(D) An overlay of loop5 and the side chain of W236
from both GlpG S201T and L62 structures on a
surface representation of the GlpG-L62 structure
viewed from the periplasm. The inhibitor (L62) is
shown in yellow stick representation. The direction
of movement of the W236 side chain is shown with
an arrow. The structural change in TM5 and W236
is essential for the formation of the S20 cavity,
which is not observed in the GlpG S201T structure,
although a detergent molecule protrudes into the
active site. Protein is color-coded according to the
biochemical properties: positively and negatively
charged amino acids in blue and red, respectively,
polar amino acids in light blue, and the remainder
in gray.
See also Figure S5.
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Rhomboid Protease Inhibition by b-lactamsinteraction with the enzyme. Relatively slow deacylation of
b-lactams indicates that they are poor substrates for GlpG,
forming a nonproductive structure and explains why a stable
acyl enzyme complex could be observed in the crystals.
Structural Changes in GlpG upon b-Lactam Binding
Comparison of the b-lactam structures with the apoenzyme
shows only a modest structural change, particularly in TM5
and loop5 (Figure 3A). In the L61 and L62 structures, loop5 is
partly lifted, with the side chain of M249 still pointing into the
active site as in the apoenzyme. Despite the formation of an
acylated enzyme and the binding of inhibitor, the active site
shows very little change and closely resembles that of the
apoenzyme (Figure 3B). The side chain of the active site serine
S201 adopts a different rotamer and points away from the
catalytic histidine, H254.
In contrast, previous structures of GlpG in complex with iso-
coumarin or fluorophosphonates showed significant changes
at the active site (Vinothkumar et al., 2010; Xue et al., 2012;Structure 21, 10Xue and Ha, 2012). In particular, the catalytic histidine formed
a covalent bond with the isocoumarin and in the presence of
fluorophosphonates, moved significantly away from the catalytic
serine (Figures S5A and S5B), which also results in the side chain
of Y205 adopting a different rotamer. Perhaps due to mode of
binding and design of the b-lactam inhibitors, such changes
are not observed in the present structures. The position of the
side chain of W236 side chain is interesting in these structures.
It faces inward in the apoenzyme (Figure 3B) and occupies
intermediate positions in isocoumarin and diisopropyl fluoro-
phosphonate (DFP) structures (Figure S5) but swings completely
out toward the bilayer in the b-lactam structures.
Formation of S20 Cavity
A comparison of the L62 structure and a previously described
structure of an active site mutant of GlpG (S201T) highlight the
changes necessary for the formation of the S20 cavity. Like in
the L62 structure, the GlpG (S201T) structure shows two deter-
gent molecules at the TM2/TM5 interface; one of these51–1058, June 4, 2013 ª2013 Elsevier Ltd All rights reserved 1055
Figure 4. Model for Deacylation
(A–C) The interaction of the water/chloride ion with
the ligand in the inhibitor structures is shown. The
water molecule (red sphere) or chloride ion (green
sphere) hydrogen-bond with the side chain of
H254, and the water molecule that also hydrogen-
bonds to H150. In the L61 and L62 structures, the
chloride ion also interacts with main chain amide
of M249. Because the carbonyl oxygen points
away from the oxyanion hole, they are geometri-
cally unfavorable for deacylation.
(D) To model a productive enzyme-inhibitor
complex, the carbonyl oxygen in the L61 structure
was rotated toward the oxyanion hole so that it is
stabilized by hydrogen bonds from H150, N154,
and a water molecule. By replacing the chloride
ion with a water molecule (red sphere), a structure
favorable for deacylation can be generated.
See also Figure S6.
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Rhomboid Protease Inhibition by b-lactamsdetergents protrudes into the active site (Vinothkumar, 2011).
The L62 and GlpG (S201T) structures are largely similar including
loop5 with the side chain of M249 pointing into the active site
(Figure 3C). Although the bulky hydrophobic detergent molecule
points into the active site in the GlpG S201Tmutant structure, no
S20 cavity forms. Presumably, because the detergent neither has
the right chemical group to form the S20 cavity, nor can form a
covalent bond with catalytic serine, the structural change
induced is limited to a minor displacement of loop5 without a
change in TM5 (Figure 3C). In contrast, the binding of the inhib-
itor results not only in partial displacement of loop5, but also a
change in TM5 and concurrent movement of the side chain of
W236 (Figures 3C and 3D), resulting in a fully formed S20 cavity,
allowing the hydrophobic carbamate group of the ligand to bind.
These structures therefore show that while it is possible for any
hydrophobic group (for example, a detergent molecule) to
interact with GlpG, formation of a productive enzyme complex
appears to be dependent on the presence of appropriate chem-
ical motifs.
The observed position of the external ligand is possibly
dictated by the crystal packing of GlpG, and the partitioning
and position of ligand may differ in presence of the membrane.
Nevertheless, the L62 structure provides an opportunity to
understand how ligand enters the active site and forms a cova-
lent complex. The initial interaction of the ligand through the1056 Structure 21, 1051–1058, June 4, 2013 ª2013 Elsevier Ltd All rights reservedTM2/TM5 interface is probably followed
by a partial displacement of loop5 and
perhaps a change in TM5, which allows
access to the catalytic serine. The con-
formation of the side chain of W236 as
observed in the apoenzyme could sup-
port the ligand, interacting with the
N-substituent of the b-lactam, thus posi-
tioning the ligand for the nucleophilic
attack. We speculate that the W236 side
chain rotates to form the S20 cavity only
after the formation of the ester bond. It
is possible that the change in TM5 could
be larger when a TM substrate binds.
However, from biochemical analysis itis evident that only a subset of residues (for instance P20-P2
subsites) interact around the active site (Strisovsky et al.,
2009), and the rest of the interactions of the TM substrate with
the enzyme is likely to be with residues in TM2 and TM5 facing
the bilayer. Thus the extent of structural change observed
in the b-lactam complexes is probably a good illustration of initial
ligand/substrate binding at the active site—that is, binding of the
substrate at the TM2/TM5 interface followed by formation of the
ester bond and S20 cavity.
A Model for Deacylation
In all structures described here, a water molecule (in the L29
structures) or chloride ion (in the L61 and L62 structures) has
been modeled close to the covalently bound inhibitor (Figures
4A–4C). Both water and chloride ions are coordinated by
hydrogen bonds to the catalytic histidine and water molecule
and in the L61 and L62 structures, the main chain amide of
M249. In data set1 of the L29 structure, this water molecule
has a lower occupancy judged from the density and higher B
factor (Figure S6). The observed angle of water/chloride to the
carbonyl oxygen of the inhibitor ranges between 91.2 and
106.8 in all the structures described here.
The final step in the proteolytic cycle of serine proteases
involves a deacylation step mediated by a water molecule, acti-
vated by the catalytic histidine. Because the water/chloride ion
Structure
Rhomboid Protease Inhibition by b-lactamshydrogen bond to catalytic histidine and the observed angles are
very close to those described by Bu¨rgi and colleagues for the
nucleophilic attack of the water on the ester bond (Bu¨rgi et al.,
1973), perhaps this indicates the likely position of the water
molecule in GlpG for the deacylation step. However because
the carbonyl oxygen of the inhibitors faces away from the oxyan-
ion hole, they are geometrically unfavorable for deacylation in the
present structures. To model a productive enzyme inhibitor
structure, the carbonyl oxygen of the L61 inhibitor was rotated
toward the oxyanion hole so that carbonyl oxygen is stabilized
by hydrogen bonds from residues H150, N154, and a water
molecule. In this geometry, a water molecule placed in the
same position as the chloride ion now achieves a favorable
conformation for the attack on the ester bond to carry out subse-
quent deacylation (Figure 4D).
DISCUSSION
The original discovery of b-lactams as inhibitors of serine
proteases was serendipitous; inhibitors originally designed for
b-lactamase were also found to inhibit elastase (Doherty et al.,
1986; Powers et al., 2002). b-lactam inhibition of GlpG follows
a similar mechanism to the inhibition of elastase (Navia et al.,
1987; Taylor et al., 1999; Wilmouth et al., 1998) and signal
peptidases (Paetzel et al., 1998), where the nucleophilic attack
of serine on the carbonyl oxygen at position 2 (Figure 1A) results
in ring opening and the formation of an acyl enzyme inter-
mediate. The efficient inhibition of rhomboid proteases by
b-lactams is illustrated by the numerous interactions formed
between enzyme and inhibitor (Figure 1D; Figure S1), and by
the slow deacylation of the acyl enzyme (Figure S4).
SARs of the b-lactams revealed that the chemical substituent
at positions 1, 3, and 4 of the b-lactam ring influenced inhibitory
activity against rhomboids (Pierrat et al., 2011). With the present
structural data, it is now possible to appreciate how this is
achieved, as summarized below.
The nature of the chemical group attached to the carbamate of
the b-lactams exerts the biggest effect on rhomboid proteases.
In the ring-opened form of the b-lactams, the N-substituent at
position 1 points into the S20 cavity and forms extensive interac-
tions with the enzyme, thus explaining why this has a large effect
(Figure 2A). The efficiency of inhibition of GlpG increases with
increasing hydrophobicity of the N-substituent (Figure 2D); this
correlates well with the previous mutagenesis study of rhomboid
substrates, which revealed preference for hydrophobic groups
at the P20 position (Strisovsky et al., 2009).
It was also observed that the efficiency of b-lactam inhibition
between different rhomboids varied. Some were more potent
inhibitors of GlpG, while others were more active against
AarA, a rhomboid protease from Providencia stuartii (Pierrat
et al., 2011). A structure-based alignment of rhomboid prote-
ases reveals differences in the nature of the amino acids that
line the S20 cavity, which would be expected to affect the
b-lactam-enzyme interaction and therefore the inhibition (Fig-
ure 2A). For example, in AarA the residues that form the wall
and the base of the S20 cavity are replaced with amino acids
with smaller side chains thus making the cavity bigger than in
GlpG (Figure S7). An analysis of the related GlpG structure
from Haemophilus influenzae (Figure S8) shows a hydrophobicStructure 21, 10cavity at the same position as in E. coli GlpG (Lemieux et al.,
2007), thus a b-lactam with a small hydrophobic group can fit
easily into it. Residues from TM2 and TM5 are the least
conserved in rhomboids and because they also form part of
the S20 cavity, this local difference could contribute to substrate
specificity.
Because the phenyl ring at position 4 of the b-lactam ring
points toward the bilayer (Figure 1C), it is not surprising that
this substituent was found to be nonessential for activity in the
SAR study (Pierrat et al., 2011).
A large extension at position 3 of the b-lactams was found to
be detrimental to GlpG inhibition. The orientation of the inhibitor
in these structures indicates that this extension would point up
toward the solvent, so it is unclear why it should have an effect
(Figure 1D). It is possible that a large hydrophobic group at this
position may discourage a facile reaction with the enzyme in
the initial step.
A comparison of the three distinct classes of inhibitor-bound
structures of GlpG reveals their mode of binding at the active
site as well as the formation and size of S20 cavity. The structural
change in TM5 is comparable in the isocoumarin and the
b-lactam structures (Figure S9). The S20 cavity in the isocoumarin
structure is smaller than those observed with b-lactams, largely
due to the position of W236 side chain and the small methoxy
substituent (Vinothkumar et al., 2010). The structure of GlpG in
complex with DFP shows the smallest change in TM5 among
the inhibitor structures, shows no S20 cavity, and the side chain
of W236 occupies a similar position to the apoenzyme but
adopts a different rotamer orientation (Figures S10A and S10B)
(Xue and Ha, 2012). When a fluorophosphonate with a larger
carboxybenzyl (Cbz) group is bound to GlpG, the S20 cavity is
observed and the inhibitor carbonyl oxygen points into it (Figures
S10C and S10D) (Xue et al., 2012). These structures further sup-
port the proposal that the nature of the chemical groups (size and
hydrophobicity) determine the size of the S20 cavity, defined by
changes in TM5 and W236 and accompanied by a partial or
complete displacement of loop5.
Chymotrypsin, a digestive serine protease, was included as a
selectivity control in the initial screen for rhomboid inhibitors.
Some b-lactams were selective against rhomboids while not
affecting chymotrypsin (Pierrat et al., 2011). It is notable that
substrates digested by chymotrypsin typically have an aromatic
group at the P1 residue (Henderson, 1970). One would therefore
expect that the hydrophobic groups, either at position 4 or
those attached to the carbamate of the b-lactams, are most
likely candidates to interact with the S1 cavity of chymotrypsin.
Because rhomboids also prefer hydrophobic residues at the
P20 position of substrate, how is the selectivity over chymo-
trypsin achieved? We propose that the substituent at position
4 of the b-lactams interacts with the S1 cavity of chymotrypsin.
This is based on the fact that deletion of the aryl ring at position
4 removes inhibition of chymotrypsin (Pierrat et al., 2011). In
contrast, the substituent at position 4 has very little effect on
GlpG or AarA. By increasing the length of the hydrophobic
linker at position 4, it may be possible to further increase the
selectivity for rhomboids. Thus the present structures of GlpG
in complex with b-lactams provide a platform for structure-
based design of more specific and potent inhibitors for rhom-
boid proteases.51–1058, June 4, 2013 ª2013 Elsevier Ltd All rights reserved 1057
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Procedures for protein purification, crystallization, and activity assay are
described in Vinothkumar et al., 2010 and Pierrat et al., 2011. A complete
description of methods can be found in the Supplemental Experimental
Procedures.
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